May 2016. Introduction



Similar documents
Annual report 2015 Scandiatransplant office

*6816* 6816 CONSENT FOR DECEASED KIDNEY DONOR ORGAN OPTIONS

Overview of Organ Donation and Transplantation

Candidates about Multiple Listing and Waiting Time Transfer

Questions and Answers for Transplant Candidates about the New Kidney Allocation System

Where Will my New Kidney Come From?

Kidneys. Kidney Failure4. Transplantation

Living Donor Paired Exchange Registry. What is Living Kidney Donor Paired Exchange?

Frequently Asked Questions

Preparing for ABO Determination, Reporting and Verification Policy Changes Webinar Script

Donating Life. The Workplace Partnership for Life Program

The Danish Bone Marrow Donor Registry DBMDR

APPLICATION FOR GENERAL MEDICAL SERVICES WITH THE CHARTER MEDICAL CENTRE

Heart transplantation

Anthem Centers of Medical Excellence (CME) Transplant Network. CONTRACT OPERATIONS MANUAL for Transplant Program

PRUSHIELD CLAIM FORM (Manual Submission) (Inpatient / Day Surgery / Outpatient Chemotherapy or Radiotherapy or Immunotherapy or Renal Dialysis)

Guidelines for Viral Hepatitis CTR Services

Organ and Tissue Donation: An Overview

The New Kidney Allocation System: Resources for Protocols and Processes webinar.

Red Blood Cell Transfusions for Sickle Cell Disease

Lymphomas after organ transplantation

Before your child has a stem cell transplant (SCT)

Index. Registry Report

How does a kidney transplant differ from dialysis?

Executive summary. Executive summary 8

Learning about Hepatitis C and Chronic Kidney Disease

Seeking Normality: Life on the Kidney Transplant List

Florida Medicaid. Transplant Services Coverage Policy

NHS Family doctor services registration GMS1

Patient Reported Outcome Measures (PROMs) in England: Update to reporting and case-mix adjusting hip and knee procedure data.

What is a Living Will?

>

CRM INTEGRATION. Swift Digital Suite CRM Integration with: Salesforce and MS Dynamics. 25 September 2015

Hydroxyurea Treatment for Sickle Cell Disease

Kidney and Pancreas Transplant Evaluation Clinics and Committee: Inpatient Nephrology Transplant Consult Service

BLOOD DONOR TESTING & LOOKBACK STUDIES Shan Yuan, MD Last Updated 2/8/ ABO Typing: Performed each time with each donation

Many people with non-hodgkin lymphoma have found an educational support group helpful. Support

Date of birth Gender NHS number (if known) Town/Country of birth. Home Telephone no. Work Telephone no.

Chapter 2 What Is Diabetes?

A Guide for Successfully Completing the Group Life Insurance Evidence of Insurability Form

Transplant Coordinator

Kidney Transplantation

S. 681 IN THE SENATE OF THE UNITED STATES

Organ and Tissue Donation

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care

Visitors to our website The LCTHF website collects information about each visitor in several ways. These may include:

Death Verification of Death and Medical Certificate of Cause of Death

Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.

Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012

THE BENEFITS OF LIVING DONOR KIDNEY TRANSPLANTATION. feel better knowing

Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents

CAREERS IN BIOMEDICAL SCIENCE & THE IBMS. Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire

PPS UNDERWRITING GUIDE FOR APPLICANTS

Lung Transplantation and Cystic Fibrosis

Organ, Tissue and Eye Donation: Glossary of Terms

Health risk assessment: a standardized framework

Saint Francis Kidney Transplant Program Issue Date: 6/9/15

Introduction to ilab Solutions for Core Directors and Staff

MONTANA NURSE AIDE REGISTRY ONLINE

The Paired Donation Network. E. Steve Woodle, M.D. Division of Transplantation University of Cincinnati

Family doctor services registration

Is a Kidney Transplant Right for Me?

HIV& AIDS BASIC FACTS. HIV & Drug Use. You are better off knowing if you have HIV. HIV & Sex. What are HIV & AIDS? HIV & Blood Products

Is a kidney transplant right for me?

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

LIVING KIDNEY DONATION

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System

Offering Testing for Hepatitis B and C in Primary Care

A Guide for Successfully Completing the Group Life Insurance Evidence of Insurability Form

Welcome to our marketing solution

Transplant Options When You Don t Have a Good Match

TA L K I N G A B O U T T R A N S P L A N TAT I O N

SWINE FLU: FROM CONTAINMENT TO TREATMENT

Pneumococcal Disease Call to Action

NATCO Introductory Education Course Objectives

CHAPTER 6. Discussion and Conclusion. patient health information, such as diagnosis, medicine orders, managing patient

Fractals and Human Biology

Seroprevalence and risk factors of Lassa fever infection in Nasarawa State, Nigeria 2013

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

INTERNACIONAL REGISTRY IN ORGAN DONATION AND TRANSPLANTATION -IRODaT

Transcription:

News from office May 2016 Introduction Main topics in this newsletter Updates in existing modules + Information on urgent patients + Articles of Association - Updates in existing YASWA modules o New parameter in infection serology - Anti-MV IgG (Morbilli virus antibody) o Liver registry New QC o Temporarily of the waiting list for a specified period - NEW Articles of Association - First step - Information on urgent heart, lung and liver patients by SMS and email All previous newsletters can be found on the web page http://www.scandiatransplant.org/news/newsletters Content 1 Introduction and purpose 2 Updates in existing YASWA modules 4 The articles of the Association 5 Urgent patient information on SMS and email 5 Purpose By this information letter, we wish to communicate to you about status and progress related to the database, collaboration with groups related to and on-going working projects. We hope that you will read it and share the information with whom it might concern. Do not hesitate to contact us for further information, ideas, problems and help. Aarhus Universitetshospital, Skejby 8200 Aarhus N Denmark www.scandiatransplant.org 1

Morbilli virus antibody Updates in existing YASWA modules New parameter in infection serology - Anti-MV IgG (Morbilli virus antibody) In all infection serology entries donor, recipients and follow up registries anti-mv igg Morbilli virus antibody has been added. Liver registry New QC A new quality control has been added in the database which discloses living liver donor were split usage have not been registered. We urge you to follow up on these missing registrations. Liver LD with no split registration 2

Temporarily of the waiting list for a specified period On patients with an active kidney, kidney-pancreas or pancreas waiting list you now have the following possibilities: - When the patient is transplantable -> To set a future temporarily withdrawn date - When the patient is transplantable -> To set a future temporarily withdrawn date in combination with a future re-entry date - When the patient is not transplantable -> To set a future activation data Temporarily withdrawn for a period When the patient is transplantable -> To set a future temporarily withdrawn date You enter a future date in Future Withdrawn from from which the patient will be not transplantable. If you insert 24-may-2016 the status will change at midnight between the 23 rd and 24 th of May. When the patient is transplantable -> To set a future temporarily withdrawn date in combination with a future re-entry date You enter a future date in Future Withdrawn from from which the patient will be not transplantable and you enter a date in Future Withdrawn to: at which date the patient will be active on the waiting list again. 3

When the patient is not transplanable -> To set a future activation data You enter a date in Future Withdrawn to: at which date the patient will be active on the waiting list again. (You also need to enter a future date in Future Withdrawn from, however the patient will stay inactice until Future Withdawn to date ) The urgency status WU: Temporarly Withdrawn until will stay unchanged meaning that the patient will be temporarly withdrawn when you save data until the until specified date. The Articles of the Association New articles At the Counsil of representatives meeting May 11, 2016 the revised articles were presented and approved. The major changes being rewriting of the purpose of, changing how the composition of the council is calculated, medical decisions are placed in groups, addition of an article on the office, groups and possibility of associate membership. The new articles are now available on the homepage for all to read: http://www.scandiatransplant.org/aboutscandiatransplant/organisation/articlesofassociationforforeninge n.pdf 4

First step - Information on urgent heart, lung and liver patients by SMS and email The office has started working on a solution for sending out information by SMS and mail on urgent heart, lung and liver recipients, instead of fax that is currently used. When a recipient changes status in YASWA to or from urgent an email and a SMS is sent to all coordinators that currently receives organ offers. The email contains the following recipient information; waiting list type, urgency status change, Scandianumber, age, blood group, gender, weight, height and diagnosis. Example The SMS only contains information on waiting list type and urgency change. Examples: Please know that this is the first step, more information will be included (donor requirements, more recipient information etc.) and you should keep your current solutions running parallel until further notice. 5